NYSE:FRX - Forest Laboratories Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Forest Laboratories (NYSE:FRX)

Forest Laboratories logoForest Laboratories, Inc. (Forest), develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company's products include Namenda, a N-methyl-D-aspartate (NMDA) antagonist for the treatment of moderate to severe dementia of the Alzheimer's type; Bystolic, a beta-blocker for the treatment of hypertension; Linzess, a guanylate cyclase type-C receptor agonist for the once-daily treatment for men and women suffering from IBS-C or CIC; Tudorza, a long-acting antimuscarinic agent for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and Viibryd, a SSRI and a 5-HT1A receptor partial agonist for the treatment of adults with depressive disorder (MDD). In February 2014, it acquired Aptalis. Effective July 2, 2014 Forest Laboratories Inc, a unit of Actavis PLC, acquired the entire share capital of Furiex Pharmaceuticals Inc.

Receive FRX News and Ratings via Email

Sign-up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Forest Laboratories (NYSE:FRX) Frequently Asked Questions

What is Forest Laboratories' stock symbol?

Forest Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "FRX."

Has Forest Laboratories been receiving favorable news coverage?

News headlines about FRX stock have trended somewhat positive on Tuesday, Accern reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Forest Laboratories earned a news sentiment score of 0.13 on Accern's scale. They also assigned news coverage about the healthcare company an impact score of 49.30 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Forest Laboratories?

Shares of FRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Forest Laboratories?

Forest Laboratories' mailing address is 909 3rd Ave, NEW YORK, NY 10022-4731, United States. The healthcare company can be reached via phone at +1-212-4217850.

MarketBeat Community Rating for Forest Laboratories (FRX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  263 (Vote Underperform)
Total Votes:  467
MarketBeat's community ratings are surveys of what our community members think about Forest Laboratories and other stocks. Vote "Outperform" if you believe FRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Forest Laboratories (NYSE:FRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/24/2016 forward)


Forest Laboratories (NYSE:FRX) Earnings History and Estimates Chart

Earnings by Quarter for Forest Laboratories (NYSE:FRX)

Forest Laboratories (NYSE FRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/29/2014Q414$0.45$0.87$959.00 million$1.05 millionViewN/AView Earnings Details
1/21/2014Q314$0.06$0.27$827.25 million$846.80 millionViewN/AView Earnings Details
10/22/2013Q2 2014$0.14$0.36$828.99 million$855.26 millionViewN/AView Earnings Details
7/23/2013Q1 2014$0.09$0.28$798.41 million$796.90 millionViewN/AView Earnings Details
4/23/2013Q4 2013$0.16$0.17$807.00 million$783.20 millionViewN/AView Earnings Details
1/15/2013Q3 2013($0.14)($0.21)$765.94 million$678.00 millionViewN/AView Earnings Details
10/16/2012$0.02$0.08ViewN/AView Earnings Details
7/17/2012$0.24$0.28ViewN/AView Earnings Details
4/17/2012$0.70$0.78ViewN/AView Earnings Details
1/17/2012$1.01$1.04ViewN/AView Earnings Details
10/18/2011$0.99$0.91ViewN/AView Earnings Details
7/19/2011$0.97$1.04ViewN/AView Earnings Details
4/19/2011$1.07$1.12ViewN/AView Earnings Details
1/18/2011$0.99$1.34ViewN/AView Earnings Details
10/19/2010Q2 2011$0.94$1.00ViewN/AView Earnings Details
7/20/2010Q1 2011$0.86$0.95ViewN/AView Earnings Details
4/20/2010Q4 2010$0.83$0.83ViewN/AView Earnings Details
1/19/2010Q3 2010$0.86$0.97ViewN/AView Earnings Details
10/20/2009Q2 2010$0.85$0.86ViewN/AView Earnings Details
7/21/2009Q1 2010$0.82$0.87ViewN/AView Earnings Details
4/21/2009Q4 2009$0.75$0.76ViewN/AView Earnings Details
1/20/2009Q3 2009$0.76$1.03ViewN/AView Earnings Details
10/21/2008Q2 2009$0.69$0.80ViewN/AView Earnings Details
7/22/2008Q1 2009$0.80$0.87ViewN/AView Earnings Details
4/15/2008Q4 2008$0.77$0.90ViewN/AView Earnings Details
1/15/2008Q3 2008$0.75$0.96ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Forest Laboratories (NYSE:FRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Forest Laboratories (NYSE FRX) Insider Trading and Institutional Ownership History

Insider Trading History for Forest Laboratories (NYSE:FRX)

Forest Laboratories (NYSE FRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2014Howard SolomonDirectorSell250,000$65.41$16,352,500.00464,881View SEC Filing  
1/23/2014Howard SolomonDirectorSell250,000$67.13$16,782,500.00714,881View SEC Filing  
1/22/2014Jerome LynchSVPSell135,625$67.28$9,124,850.0066,577View SEC Filing  
8/26/2013Lawrence OlanoffDirectorSell1,104$42.96$47,427.8491,354View SEC Filing  
8/21/2013Perier Francis, Jr.CFOSell12,000$43.00$516,000.0099,439View SEC Filing  
9/4/2012Carl C IcahnMajor ShareholderBuy86,848$34.64$3,008,414.72View SEC Filing  
8/29/2012Carl C IcahnMajor ShareholderBuy331,406$34.65$11,483,217.90View SEC Filing  
8/24/2012Carl C IcahnMajor ShareholderBuy1,343,837$34.57$46,456,445.09View SEC Filing  
8/21/2012Carl C IcahnMajor ShareholderBuy1,962,011$34.18$67,061,535.98View SEC Filing  
(Data available from 1/1/2013 forward)


Forest Laboratories (NYSE FRX) News Headlines


SEC Filings

Forest Laboratories (NYSE:FRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Forest Laboratories (NYSE:FRX) Income Statement, Balance Sheet and Cash Flow Statement


Forest Laboratories (NYSE FRX) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.